Wenzhou Ruilisen Biological Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Wenzhou Ruilisen Biological Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 12 (Vehicles) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SCHWEEK. The owner is based in Wenzhou, Zhejiang.

Rm.402, Bldg.C, No. 1, Ningxiang Rd.,

Wenzhou, Zhejiang 325700 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SCHWEEK
SCHWEEK
Registered 2021

Trademark Classifications

Wenzhou Ruilisen Biological Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Wenzhou Ruilisen Biological Technology Co., Ltd. have?

Wenzhou Ruilisen Biological Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Wenzhou Ruilisen Biological Technology Co., Ltd. file in?

Wenzhou Ruilisen Biological Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 12 (Vehicles). Class 12 covers vehicles; apparatus for locomotion by land, air or water.

What are Wenzhou Ruilisen Biological Technology Co., Ltd.'s most well-known trademarks?

Wenzhou Ruilisen Biological Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SCHWEEK. These are among 1 currently registered trademark in the portfolio.

What is Wenzhou Ruilisen Biological Technology Co., Ltd.'s trademark registration success rate?

Wenzhou Ruilisen Biological Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.